Katharine Hsu
Director, Tri-Institutional M.D.-Ph.D. Program · New York Presbyterian Hospital
Credentials: · · · ·
History
PresentTri-Institutional M.D.-Ph.D. Program · New York Presbyterian Hospital
Research
Prognostic Mutations in Myelodysplastic Syndrome after Stem-Cell Transplantation
New England Journal of Medicine · 2017 · 655 citations
Blood · 2005 · First of 9 authors · Corresponding · 379 citations
HLA-C-dependent prevention of leukemia relapse by donor activating KIR2DS1
New England Journal of Medicine · 2012 · Last of 11 authors · 361 citations
19 papers
18 papers
17 papers
- MP
14 papers
13 papers
- EP
12 papers
12 papers
- AJ
11 papers
Grants
- 2024–2029
Weill Cornell/Rockefeller/Sloan Kettering MST Program
National Institute of General Medical Sciences · T32
Contact PI · $6.6M · Weill Medical Coll of Cornell Univ
- 2026–2028
Innate & Adaptive Determinants of Post-CAR Cytokine Release Syndrome
National Cancer Institute · R21
Contact PI · $452.5K · Sloan-Kettering Inst Can Research
- 2021–2027
HCMV-Induced Innate-Like CD8 T Cells and Allogeneic HCT Outcome
National Institute of Allergy and Infectious Diseases · R01
Contact PI · $3.6M · Sloan-Kettering Inst Can Research
- 2021–2025
Machine Learning with Immunogenetics for the Prediction of Hematopoietic Cell Transplant Outcomes
National Heart, Lung, and Blood Institute · R01
Contact PI · $2.4M · Sloan-Kettering Inst Can Research